![Titan Pharmaceuticals Inc](/common/images/company/N_TTNP.png)
Titan Pharmaceuticals Inc (TTNP)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 32.14 | -103.779 | -80.939 | -139.374 | -207.19 | -109.147 | -169.366 | -91.716 |
Return on Equity (%) | 50.889 | -203.687 | -242.144 | -398.306 | -734.824 | -202.445 | -313.982 | -139.138 |
Return on Invested Capital (%) | 43.04 | -164.496 | -109.755 | -209.633 | -157.815 | -208.935 | -319.594 | -182.908 |
Operating Margin (%) | 34.086 | -6482.791 | -122.937 | -428.995 | -137.205 | -575.098 | -1832.316 | -3026.63 |
Net Profit Margin (%) | 34.086 | -6654.419 | -140.647 | -455.774 | -377.057 | -575.098 | -1832.316 | -3026.63 |
Book Value Per Share | 0.605 | 0.039 | 0.502 | 0.025 | 0.456 | 0.488 | 0.087 | 0.401 |
Earnings Per Share | 0.235 | -0.656 | -0.684 | -0.284 | -2.355 | -0.834 | -0.653 | -0.336 |
Cash Per Share | 0.642 | 0.345 | 0.683 | 0.09 | 0.699 | 0.574 | 0.188 | 0.408 |
Working Capital Per Share | 0.595 | 0.176 | 0.723 | 0.081 | 0.401 | 0.433 | 0.062 | 0.397 |
Operating Profit Per Share | 0.691 | 0.01 | 0.447 | 0.044 | 0.601 | 0.126 | 0.036 | 0.011 |
EBIT Per Share | 0.235 | -0.656 | -0.663 | -0.284 | -0.956 | -0.834 | -0.653 | -0.336 |
EBITDA Per Share | 0.235 | -0.656 | -0.663 | -0.284 | -0.956 | -0.834 | -0.653 | -0.336 |
Free Cash Flow Per Share | 0.226 | -0.667 | -0.681 | -0.284 | -2.323 | -0.853 | -0.666 | -0.343 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 21,2M | 21,2M | 13,01M | 57,38M | 7,14M | 9,91M | 15,02M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 15,02M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -1709.184 | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | -1709.184 | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,33M |
Ratio cours/bénéfice | -0,6 |
Ratio prix/ventes | 18,08 |
Ratio prix/liquidités | 0,49 |
Ratio prix/valeur comptable | 0,5 |
Rendement de dividende | - |
Actions en circulation | 914,23k |
Volume moyen (1 semaine) | 8,73k |
Volume moyen (1 mois) | 32,53k |
Variation sur 52 semaines | -38,41% |
Plus haut sur 52 semaines | 14,80 |
Plus bas sur 52 semaines | 3,03 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales